United States v. Glaxo Group Ltd.

From WikiMD.com Medical Encyclopedia



United States v. Glaxo Group Ltd.[edit | edit source]

United States v. Glaxo Group Ltd. was a significant United States Supreme Court case decided in 1973. The case addressed issues related to patent law and antitrust law in the context of the pharmaceutical industry.

Background[edit | edit source]

The case arose from a dispute involving the Glaxo Group Ltd., a major pharmaceutical company, and the United States government. The government alleged that Glaxo had engaged in anticompetitive practices by using its patents to unlawfully extend its monopoly over certain pharmaceutical products.

Legal Issues[edit | edit source]

The primary legal issue in the case was whether Glaxo's use of its patents violated antitrust laws, specifically the Sherman Antitrust Act. The government argued that Glaxo's licensing agreements and patent practices restricted competition and maintained artificially high prices for its drugs.

Supreme Court Decision[edit | edit source]

The Supreme Court ruled in favor of the United States, holding that Glaxo's patent practices constituted an unlawful restraint of trade. The Court's decision emphasized the importance of balancing patent rights with the need to maintain competitive markets.

Impact[edit | edit source]

The decision in United States v. Glaxo Group Ltd. had a significant impact on the pharmaceutical industry and patent law. It reinforced the principle that patent rights cannot be used to justify anticompetitive behavior and highlighted the role of antitrust laws in regulating the use of patents.

Related pages[edit | edit source]

References[edit | edit source]

  • "United States v. Glaxo Group Ltd.," 410 U.S. 52 (1973).
  • "Antitrust and Patent Law: The Supreme Court's Decision in United States v. Glaxo Group Ltd.," Journal of Law and Economics.
Justice Byron White, who delivered the opinion of the Court in United States v. Glaxo Group Ltd.
WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD